Adriamycin cardiotoxicity: report of an unusual case with features resembling endomyocardial fibrosis.
- 1 June 1981
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 34 (6) , 602-605
- https://doi.org/10.1136/jcp.34.6.602
Abstract
A case of adriamycin cardiotoxicity occurring in a 5 yr old boy treated for rhabdomyosarcoma is reported. In addition to the usual features of myofibrillary degeneration associated with adriamycin, extreme endocaridal fibrosis and mural thrombosis affecting the apical segments of both ventricles but particularly the left ventricle was seen at necropsy. The changes resembled classical endomyocardial fibrosis.This publication has 11 references indexed in Scilit:
- Adriamycin-induced myocardial lesions Report of a WorkshopThe American Journal of Surgical Pathology, 1977
- Adriamycin cardiotoxicity in children.Case reports, literature review, and risk factorsCancer, 1977
- Cardiotoxicity of adriamycin and related anthracyclinesCancer Treatment Reviews, 1976
- Endomyocardial fibrosis associated with daunorubicin therapy.Heart, 1976
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973
- Clinical trials with adriamycinCancer, 1971
- Phase I and preliminary phase II evaluation of adriamycin (NSC 123127).1970
- Endomyocardial fibrosis in Uganda (Davies' disease). Part II: An epidemiologic, clinical, and pathologic studyAmerican Heart Journal, 1968
- Endomyocardial fibrosis in Uganda (Davies' disease). Part I: An epidemiologic, clinical, and pathologic studyAmerican Heart Journal, 1967
- THE PATHOLOGY OF ENDOMYOCARDIAL FIBROSIS IN UGANDAHeart, 1955